These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Mark One)
|
||
|
x
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
For the fiscal year ended October 31, 2014
|
|
or
|
||
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
For the transition period from to
|
|
Delaware
|
|
46-4254555
|
|
State or other jurisdiction of
Incorporation or organization
|
|
I.R.S. Employer
Identification No.
|
|
Title of each class
|
|
Name of each exchange on which registered
|
|
Common Stock
par value $0.01 per share
|
|
New York Stock Exchange, Inc.
|
|
Large accelerated filer
å
|
|
Accelerated filer
å
|
|
Non-accelerated filer
x
|
|
Smaller reporting company
å
|
|
|
|
|
|
(Do not check if a smaller
reporting company)
|
|
|
|
Document Description
|
|
10-K Part
|
|
Portions of the Proxy Statement for the Annual Meeting of Stockholders to be held on March 19, 2015 and to be filed pursuant to Regulation 14A within 120 days after registrant's fiscal year ended October 31, 2014 are incorporated by reference into Part III of this Report.
|
|
III
|
|
|
|
Page
|
|
|
||
|
|
||
|
|
||
|
|
||
|
•
|
Invest in new wireless communication measurement solutions.
We are investing in the development of new wireless communications test solutions to satisfy the market which is being driven by the explosive growth in mobile data and evolving wireless standards.
|
|
•
|
Invest in modular solutions.
The market for modular solutions is expected to grow faster than the overall electronic measurement market. We are investing to leverage our strength in feature-rich instrumentation into a portfolio of modular measurement solutions.
|
|
•
|
Accelerate the value migration to software solutions.
An increasing percentage of measurement science and functionality is delivered through software solutions. Our portfolio of embedded software solutions, stand-alone software packages and software productivity tools is extensive and represents a significant corporate asset. We will continue to invest in software development to capitalize on the growth opportunity in software.
|
|
•
|
reduced demand for our products, delays in the shipment of orders or increases in order cancellations;
|
|
•
|
increased risk of excess and obsolete inventories;
|
|
•
|
increased price pressure for our products and services; and
|
|
•
|
greater risk of impairment to the value, and a detriment to the liquidity, of our future investment portfolio.
|
|
•
|
properly identify customer needs;
|
|
•
|
innovate and develop new technologies, services and applications;
|
|
•
|
successfully commercialize new technologies in a timely manner;
|
|
•
|
manufacture and deliver our products in sufficient volumes and on time;
|
|
•
|
differentiate our offerings from our competitors' offerings;
|
|
•
|
price our products competitively;
|
|
•
|
anticipate our competitors' development of new products, services or technological innovations; and control product quality in our manufacturing process.
|
|
•
|
interruption to transportation flows for delivery of parts to us and finished goods to our customers;
|
|
•
|
changes in foreign currency exchange rates;
|
|
•
|
changes in a specific country's or region's political, economic or other conditions;
|
|
•
|
trade protection measures, sanctions, and import or export licensing requirements or restrictions;
|
|
•
|
negative consequences from changes in tax laws;
|
|
•
|
difficulty in staffing and managing widespread operations;
|
|
•
|
differing labor regulations;
|
|
•
|
differing protection of intellectual property;
|
|
•
|
unexpected changes in regulatory requirements; and
|
|
•
|
volatile political environments or geopolitical turmoil, including regional conflicts, terrorism, and war.
|
|
•
|
the retention of key employees and/or customers;
|
|
•
|
the management of facilities and employees in different geographic areas; and
|
|
•
|
the compatibility of our infrastructure, policies and organizations with those of the acquired company.
|
|
•
|
requiring a portion of our cash flow from operations to make interest payments on this debt;
|
|
•
|
increasing our vulnerability to general adverse economic and industry conditions;
|
|
•
|
reducing the cash flow available to fund capital expenditures and other corporate purposes and to grow our business; and
|
|
•
|
limiting our flexibility in planning for, or reacting to, changes in our business and the industry.
|
|
•
|
prior to the separation, our business has been operated by Agilent as part of its broader corporate organization, rather than as an independent company. Agilent or one of its affiliates performed various corporate functions for us such as legal, treasury, accounting, auditing, human resources, corporate affairs and finance. Our historical financial results reflect allocations of corporate expenses from Agilent for such functions and are likely to be less than the expenses we would have incurred had we operated as a separate publicly-traded company. Following the separation, our cost related to such functions previously performed by Agilent may therefor increase;
|
|
•
|
our business was integrated with the other businesses of Agilent. Historically, we shared economies of scope and scale in costs, employees, vendor relationships and customer relationships. Although our transition agreements with Agilent took effect upon the separation, these arrangements may not fully capture the benefits that we enjoyed as a result of being integrated with Agilent and may result in the company paying higher charges than in the past for these services. This could have an adverse effect on our results of operations and financial condition following the separation;
|
|
•
|
generally, our working capital requirements and capital for our general corporate purposes, including acquisitions and capital expenditures, have historically been satisfied as part of the corporate-wide cash management policies of Agilent. Following the separation, we may need to obtain additional financing from banks, through public offerings or private placements of debt or equity securities, strategic relationships or other arrangements;
|
|
•
|
after the separation, the cost of capital for our business may be higher than Agilent's cost of capital prior to the separation; and
|
|
•
|
our historical financial information does not reflect the debt or the associated interest expense that we have incurred as part of the separation and distribution.
|
|
•
|
a distinct investment identity allowing investors to evaluate the merits, performance and future prospects of Keysight separately from Agilent;
|
|
•
|
more effective pursuit of each company's distinct operating priorities and strategies;
|
|
•
|
more efficient allocation of capital for both Agilent and Keysight;
|
|
•
|
direct access by Keysight to the capital markets; and
|
|
•
|
facilitation of incentive compensation arrangements for employees more directly tied to the performance of the relevant company's business, and potential enhancement of employee hiring and retention by, among other things, improving the alignment of management and employee incentives with performance and growth objectives, while at the same time creating an independent equity structure that will facilitate our ability to affect future acquisitions utilizing Keysight common stock.
|
|
•
|
was insolvent;
|
|
•
|
was rendered insolvent by reason of the separation and distribution;
|
|
•
|
had remaining assets constituting unreasonably small capital; or
|
|
•
|
intended to incur, or believed it would incur, debts beyond its ability to pay these debts as they matured,
|
|
•
|
actual or anticipated fluctuations in our operating results due to factors related to our business;
|
|
•
|
success or failure of our business strategy;
|
|
•
|
our quarterly or annual earnings, or those of other companies in our industry;
|
|
•
|
our ability to obtain third-party financing as needed;
|
|
•
|
announcements by us or our competitors of significant acquisitions or dispositions;
|
|
•
|
changes in accounting standards, policies, guidance, interpretations or principles;
|
|
•
|
the failure of securities analysts to cover our common stock;
|
|
•
|
changes in earnings estimates by securities analysts or our ability to meet those estimates;
|
|
•
|
the operating and share price performance of other comparable companies;
|
|
•
|
investor perception of our company;
|
|
•
|
natural or other disasters that investors believe may affect us;
|
|
•
|
overall market fluctuations;
|
|
•
|
results from any material litigation or government investigations;
|
|
•
|
changes in laws or regulations affecting our business; and
|
|
•
|
general economic conditions and other external factors.
|
|
•
|
the inability of our shareholders to call a special meeting;
|
|
•
|
the inability of our shareholders to act without a meeting of shareholders;
|
|
•
|
rules regarding how shareholders may present proposals or nominate directors for election at shareholder meetings;
|
|
•
|
the right of our board to issue preferred stock without shareholder approval;
|
|
•
|
the division of our board of directors into three classes of directors, with each class serving a staggered three-year term, and this classified board provision could have the effect of making the replacement of incumbent directors more time consuming and difficult;
|
|
•
|
a provision that shareholders may only remove directors with cause;
|
|
•
|
the ability of our directors, and not shareholders, to fill vacancies on our board of directors; and
|
|
•
|
the requirement that the affirmative vote of shareholders holding at least 80% of our voting stock is required to amend certain provisions in our amended and restated certificate of incorporation (relating to the number, term and removal of our directors, the filling of our board vacancies, the advance notice to be given for nominations for elections of directors, the calling of special meetings of shareholders, shareholder action by written consent, the ability of the board of directors to amend the bylaws, elimination of liability of directors to the extent permitted by Delaware law, exclusive forum for certain types of actions and proceedings that may be initiated by our shareholders and amendments of the certificate of incorporation) and certain provisions in our amended and restated bylaws (relating to the calling of special meetings of shareholders, the business that may be conducted or considered at annual or special meetings, the advance notice of shareholder business and nominations, shareholder action by written consent, the number, tenure, qualifications and removal of our directors, the filling of our board vacancies, director and officer indemnification and amendments of the bylaws).
|
|
|
Years Ended October 31,
|
||||||||||||||||||
|
|
2014
|
|
2013
|
|
2012
|
|
2011
|
|
2010
|
||||||||||
|
|
(in millions, except per share data)
|
||||||||||||||||||
|
Combined and Consolidated Statement of Operations Data:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Net revenue
|
$
|
2,933
|
|
|
$
|
2,888
|
|
|
$
|
3,315
|
|
|
$
|
3,316
|
|
|
$
|
2,706
|
|
|
Income before taxes
|
$
|
475
|
|
|
$
|
501
|
|
|
$
|
746
|
|
|
$
|
749
|
|
|
$
|
360
|
|
|
Net income
|
$
|
392
|
|
|
$
|
457
|
|
|
$
|
841
|
|
|
$
|
787
|
|
|
$
|
355
|
|
|
Basic and diluted net income per share
(a)
|
$
|
2.35
|
|
|
$
|
2.74
|
|
|
$
|
5.04
|
|
|
$
|
4.71
|
|
|
$
|
2.13
|
|
|
Basic and diluted average shares outstanding
(a)
|
167
|
|
|
167
|
|
|
167
|
|
|
167
|
|
|
167
|
|
|||||
|
|
October 31,
|
||||||||||||||||||
|
|
2014
|
|
2013
|
|
2012
|
|
2011
|
|
2010
|
||||||||||
|
|
(in millions)
|
||||||||||||||||||
|
Combined and Consolidated Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Cash and cash equivalents and short-term investments
|
$
|
810
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Working capital
|
$
|
1,081
|
|
|
$
|
412
|
|
|
$
|
398
|
|
|
$
|
272
|
|
|
$
|
199
|
|
|
Total assets
|
$
|
3,050
|
|
|
$
|
2,028
|
|
|
$
|
2,133
|
|
|
$
|
1,908
|
|
|
$
|
1,766
|
|
|
Long-term debt
|
$
|
1,099
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Stockholders'/Invested equity
|
$
|
769
|
|
|
$
|
1,245
|
|
|
$
|
1,305
|
|
|
$
|
996
|
|
|
$
|
817
|
|
|
|
Years Ended October 31,
|
|
2014 over 2013
% Change |
|
2013 over 2012
% Change |
||||||||||
|
|
2014
|
|
2013
|
|
2012
|
|
|||||||||
|
|
(in millions)
|
|
|
|
|
||||||||||
|
Orders
|
$
|
2,963
|
|
|
$
|
2,866
|
|
|
$
|
3,280
|
|
|
3%
|
|
(13)%
|
|
Net revenue:
|
|
|
|
|
|
|
|
|
|
||||||
|
Products
|
$
|
2,479
|
|
|
$
|
2,434
|
|
|
$
|
2,862
|
|
|
2%
|
|
(15)%
|
|
Services and other
|
454
|
|
|
454
|
|
|
453
|
|
|
—%
|
|
—%
|
|||
|
Total net revenue
|
$
|
2,933
|
|
|
$
|
2,888
|
|
|
$
|
3,315
|
|
|
2%
|
|
(13)%
|
|
|
Years Ended October 31,
|
|
2014 over 2013
Ppts Change |
|
2013 over 2012
Ppts Change |
|||||||
|
|
2014
|
|
2013
|
|
2012
|
|
||||||
|
% of total net revenue:
|
|
|
|
|
|
|
|
|
|
|||
|
Products
|
85
|
%
|
|
84
|
%
|
|
86
|
%
|
|
1 ppt
|
|
(2) ppt
|
|
Services and other
|
15
|
%
|
|
16
|
%
|
|
14
|
%
|
|
(1) ppt
|
|
2 ppt
|
|
Total
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
|
|
|
|
|
Years Ended October 31,
|
|
2014 over 2013
Change |
|
2013 over 2012
Change |
|||||||
|
|
2014
|
|
2013
|
|
2012
|
|
||||||
|
Gross margin on products
|
56.3
|
%
|
|
57.1
|
%
|
|
57.8
|
%
|
|
(1) ppt
|
|
(1) ppt
|
|
Gross margin on services and other
|
49.4
|
%
|
|
51.3
|
%
|
|
50.1
|
%
|
|
(2) ppt
|
|
1 ppt
|
|
Total gross margin
|
55.2
|
%
|
|
56.2
|
%
|
|
56.7
|
%
|
|
(1) ppt
|
|
(1) ppt
|
|
Operating margin
|
16.0
|
%
|
|
17.2
|
%
|
|
22.1
|
%
|
|
(1) ppt
|
|
(5) ppts
|
|
(in millions)
|
|
|
|
|
|
|
|
|
|
||||||
|
Research and development
|
$
|
361
|
|
|
$
|
375
|
|
|
$
|
377
|
|
|
(4)%
|
|
(1)%
|
|
Selling, general and administrative
|
$
|
790
|
|
|
$
|
752
|
|
|
$
|
771
|
|
|
5%
|
|
(2)%
|
|
|
Years Ended October 31,
|
||||||||||
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
|
(in millions)
|
||||||||||
|
Provision (benefit) for income taxes
|
$
|
83
|
|
|
$
|
44
|
|
|
$
|
(95
|
)
|
|
|
Years Ended October 31,
|
|
2014 over 2013
Change |
|
2013 over 2012
Change |
||||||||||
|
|
2014
|
|
2013
|
|
2012
|
|
|||||||||
|
|
(in millions)
|
|
|
|
|
||||||||||
|
Total net revenue
|
$
|
2,533
|
|
|
$
|
2,493
|
|
|
$
|
2,942
|
|
|
2%
|
|
(15)%
|
|
|
Years Ended October 31,
|
|
2014 over 2013
Change |
|
2013 over 2012
Change |
|||||||
|
|
2014
|
|
2013
|
|
2012
|
|
||||||
|
Total gross margin
|
57.2
|
%
|
|
58.3
|
%
|
|
58.0
|
%
|
|
(1) ppt
|
|
—
|
|
Operating margin
|
18.6
|
%
|
|
18.1
|
%
|
|
22.8
|
%
|
|
1 ppt
|
|
(5) ppts
|
|
(in millions)
|
|
|
|
|
|
|
|
|
|
||||||
|
Research and development
|
$
|
348
|
|
|
$
|
356
|
|
|
$
|
367
|
|
|
(2)%
|
|
(3)%
|
|
Selling, general and administrative
|
$
|
630
|
|
|
$
|
646
|
|
|
$
|
672
|
|
|
(2)%
|
|
(4)%
|
|
Income from operations
|
$
|
472
|
|
|
$
|
451
|
|
|
$
|
669
|
|
|
5%
|
|
(33)%
|
|
|
Years Ended October 31,
|
|
2014 over 2013
Change |
|
2013 over 2012
Change |
||||||||||
|
|
2014
|
|
2013
|
|
2012
|
|
|||||||||
|
|
(in millions)
|
|
|
|
|
||||||||||
|
Total net revenue
|
$
|
400
|
|
|
$
|
395
|
|
|
$
|
373
|
|
|
1%
|
|
6%
|
|
|
Years Ended October 31,
|
|
2014 over 2013
Change |
|
2013 over 2012
Change |
|||||||
|
|
2014
|
|
2013
|
|
2012
|
|
||||||
|
Total gross margin
|
46.1
|
%
|
|
48.1
|
%
|
|
48.2
|
%
|
|
(2) ppts
|
|
—
|
|
Operating margin
|
21.8
|
%
|
|
23.5
|
%
|
|
22.0
|
%
|
|
(2) ppts
|
|
2 ppts
|
|
(in millions)
|
|
|
|
|
|
|
|
|
|
||||||
|
Research and development
|
$
|
10
|
|
|
$
|
10
|
|
|
$
|
8
|
|
|
—%
|
|
20%
|
|
Selling, general and administrative
|
$
|
87
|
|
|
$
|
87
|
|
|
$
|
90
|
|
|
—%
|
|
(3)%
|
|
Income from operations
|
$
|
87
|
|
|
$
|
93
|
|
|
$
|
82
|
|
|
(6)%
|
|
14%
|
|
|
Less than one
year
|
|
One to three years
|
|
Three to five years
|
|
More than five years
|
||||||||
|
Operating leases
|
$
|
32
|
|
|
$
|
54
|
|
|
$
|
35
|
|
|
$
|
41
|
|
|
Interest on senior notes
|
44
|
|
|
88
|
|
|
88
|
|
|
136
|
|
||||
|
Commitments to contract manufacturers and suppliers
|
240
|
|
|
2
|
|
|
—
|
|
|
—
|
|
||||
|
Retirement plans
|
46
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Other purchase commitments
|
33
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Total
|
$
|
395
|
|
|
$
|
144
|
|
|
$
|
123
|
|
|
$
|
177
|
|
|
|
Less than one
year
|
|
One to three years
|
|
Three to five years
|
|
More than five years
|
||||||||
|
Senior notes
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
500
|
|
|
$
|
600
|
|
|
Index to Combined and Consolidated Financial Statements
|
|
Page
|
|
|
|
|
|
Combined and Consolidated Financial Statements:
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
Years Ended October 31,
|
||||||||||
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
|
(in millions, except per
share data)
|
||||||||||
|
Net revenue:
|
|
|
|
|
|
||||||
|
Products
|
$
|
2,479
|
|
|
$
|
2,434
|
|
|
$
|
2,862
|
|
|
Services and other
|
454
|
|
|
454
|
|
|
453
|
|
|||
|
Total net revenue
|
2,933
|
|
|
2,888
|
|
|
3,315
|
|
|||
|
Costs and expenses:
|
|
|
|
|
|
||||||
|
Cost of products
|
1,083
|
|
|
1,044
|
|
|
1,208
|
|
|||
|
Cost of services and other
|
230
|
|
|
221
|
|
|
226
|
|
|||
|
Total costs
|
1,313
|
|
|
1,265
|
|
|
1,434
|
|
|||
|
Research and development
|
361
|
|
|
375
|
|
|
377
|
|
|||
|
Selling, general and administrative
|
790
|
|
|
752
|
|
|
771
|
|
|||
|
Total costs and expenses
|
2,464
|
|
|
2,392
|
|
|
2,582
|
|
|||
|
Income from operations
|
469
|
|
|
496
|
|
|
733
|
|
|||
|
Interest expense
|
(3
|
)
|
|
—
|
|
|
—
|
|
|||
|
Other income (expense), net
|
9
|
|
|
5
|
|
|
13
|
|
|||
|
Income before taxes
|
475
|
|
|
501
|
|
|
746
|
|
|||
|
Provision (benefit) for income taxes
|
83
|
|
|
44
|
|
|
(95
|
)
|
|||
|
Net income
|
$
|
392
|
|
|
$
|
457
|
|
|
$
|
841
|
|
|
|
|
|
|
|
|
||||||
|
Net income per share - basic and diluted
(a)
|
$
|
2.35
|
|
|
$
|
2.74
|
|
|
$
|
5.04
|
|
|
Basic and diluted average shares outstanding
(a)
|
167
|
|
|
167
|
|
|
167
|
|
|||
|
|
Years Ended October 31,
|
|||||||||||
|
|
2014
|
|
2013
|
|
2012
|
|
||||||
|
|
(in millions)
|
|
||||||||||
|
Net income
|
$
|
392
|
|
|
$
|
457
|
|
|
$
|
841
|
|
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
||||||
|
Unrealized gain on investments, net of tax (expense) of $(4), $(3) and zero
|
8
|
|
|
5
|
|
|
—
|
|
|
|||
|
Unrealized gain on derivative instruments, net of tax (expense) of $(2), zero and zero
|
3
|
|
|
—
|
|
|
—
|
|
|
|||
|
Foreign currency translation, net of tax (expense) benefit of $1, $(6) and zero
|
(72
|
)
|
|
(75
|
)
|
|
(14
|
)
|
|
|||
|
Net defined benefit pension cost and post-retirement plan costs:
|
|
|
|
|
|
|
||||||
|
Change in actuarial net loss, net of tax benefit of $13, zero and zero
|
(38
|
)
|
|
—
|
|
|
—
|
|
|
|||
|
Change in net prior service credit, net of tax benefit of $3, zero and zero
|
(5
|
)
|
|
—
|
|
|
—
|
|
|
|||
|
Other comprehensive loss
|
(104
|
)
|
|
(70
|
)
|
|
(14
|
)
|
|
|||
|
Total comprehensive income
|
$
|
288
|
|
|
$
|
387
|
|
|
$
|
827
|
|
|
|
|
October 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
|
(in millions, except
par value and
share data)
|
||||||
|
ASSETS
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
810
|
|
|
$
|
—
|
|
|
Accounts receivable, net
|
357
|
|
|
340
|
|
||
|
Receivable from Agilent
|
23
|
|
|
—
|
|
||
|
Inventory
|
498
|
|
|
502
|
|
||
|
Deferred tax assets
|
83
|
|
|
65
|
|
||
|
Other current assets
|
79
|
|
|
65
|
|
||
|
Total current assets
|
1,850
|
|
|
972
|
|
||
|
Property, plant and equipment, net
|
470
|
|
|
469
|
|
||
|
Goodwill
|
392
|
|
|
419
|
|
||
|
Other intangible assets, net
|
18
|
|
|
20
|
|
||
|
Long-term investments
|
63
|
|
|
44
|
|
||
|
Long-term deferred tax assets
|
163
|
|
|
88
|
|
||
|
Other assets
|
94
|
|
|
16
|
|
||
|
Total assets
|
$
|
3,050
|
|
|
$
|
2,028
|
|
|
LIABILITIES AND EQUITY
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable
|
$
|
173
|
|
|
$
|
131
|
|
|
Payable to Agilent
|
125
|
|
|
—
|
|
||
|
Employee compensation and benefits
|
167
|
|
|
142
|
|
||
|
Deferred revenue
|
175
|
|
|
190
|
|
||
|
Income and other taxes payable
|
72
|
|
|
55
|
|
||
|
Other accrued liabilities
|
57
|
|
|
42
|
|
||
|
Total current liabilities
|
769
|
|
|
560
|
|
||
|
Long-term deferred revenue
|
69
|
|
|
94
|
|
||
|
Long-term debt
|
1,099
|
|
|
—
|
|
||
|
Retirement and post-retirement benefits
|
213
|
|
|
—
|
|
||
|
Other long-term liabilities
|
131
|
|
|
129
|
|
||
|
Total liabilities
|
2,281
|
|
|
783
|
|
||
|
Commitments and contingencies (Note 17)
|
|
|
|
|
|
||
|
Stockholders' equity:
|
|
|
|
||||
|
Agilent net investment
|
—
|
|
|
1,214
|
|
||
|
Common stock; $0.01 par value; 1 billion shares authorized; 167 million shares issued and outstanding at October 31, 2014, and no shares issued and outstanding at October 31, 2013
|
2
|
|
|
—
|
|
||
|
Additional paid-in-capital
|
1,002
|
|
|
|
|
||
|
Retained earnings
|
101
|
|
|
—
|
|
||
|
Accumulated other comprehensive income (loss)
|
(336
|
)
|
|
31
|
|
||
|
Total stockholders' equity
|
769
|
|
|
1,245
|
|
||
|
Total liabilities and equity
|
$
|
3,050
|
|
|
$
|
2,028
|
|
|
|
Years Ended October 31,
|
||||||||||
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
|
(in millions)
|
||||||||||
|
Cash flows from operating activities:
|
|
|
|
|
|
||||||
|
Net income
|
$
|
392
|
|
|
$
|
457
|
|
|
$
|
841
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
||||||
|
Depreciation and amortization
|
84
|
|
|
77
|
|
|
65
|
|
|||
|
Share-based compensation
|
43
|
|
|
41
|
|
|
38
|
|
|||
|
Excess tax benefit on share based plans
|
(4
|
)
|
|
—
|
|
|
—
|
|
|||
|
Deferred taxes
|
23
|
|
|
14
|
|
|
(118
|
)
|
|||
|
Excess and obsolete inventory
|
33
|
|
|
21
|
|
|
14
|
|
|||
|
Asset impairment charges
|
—
|
|
|
1
|
|
|
—
|
|
|||
|
Other, net
|
(1
|
)
|
|
1
|
|
|
1
|
|
|||
|
Changes in assets and liabilities:
|
|
|
|
|
|
||||||
|
Accounts receivable, net
|
(25
|
)
|
|
44
|
|
|
(3
|
)
|
|||
|
Inventory
|
(31
|
)
|
|
(53
|
)
|
|
(46
|
)
|
|||
|
Accounts payable
|
32
|
|
|
(24
|
)
|
|
(23
|
)
|
|||
|
Related party, net
|
23
|
|
|
—
|
|
|
—
|
|
|||
|
Employee compensation and benefits
|
30
|
|
|
—
|
|
|
(32
|
)
|
|||
|
Income and other taxes payable
|
63
|
|
|
(2
|
)
|
|
(5
|
)
|
|||
|
Other assets and liabilities
|
(99
|
)
|
|
(11
|
)
|
|
(8
|
)
|
|||
|
Net cash provided by operating activities
|
563
|
|
|
566
|
|
|
724
|
|
|||
|
Cash flows from investing activities:
|
|
|
|
|
|
||||||
|
Purchases of property, plant and equipment
|
(70
|
)
|
|
(69
|
)
|
|
(103
|
)
|
|||
|
Acquisitions of businesses and intangible assets, net of cash acquired
|
(11
|
)
|
|
(1
|
)
|
|
(69
|
)
|
|||
|
Purchase of investments
|
—
|
|
|
(15
|
)
|
|
—
|
|
|||
|
Change in restricted cash, cash equivalents and investments
|
(2
|
)
|
|
—
|
|
|
—
|
|
|||
|
Other
|
1
|
|
|
—
|
|
|
—
|
|
|||
|
Net cash used in investing activities
|
(82
|
)
|
|
(85
|
)
|
|
(172
|
)
|
|||
|
Cash flows from financing activities:
|
|
|
|
|
|
||||||
|
Issuance of senior notes
|
1,099
|
|
|
—
|
|
|
—
|
|
|||
|
Debt issuance costs
|
(10
|
)
|
|
—
|
|
|
—
|
|
|||
|
Proceeds from short term borrowings
|
2
|
|
|
—
|
|
|
—
|
|
|||
|
Repayment of debts and credit facility
|
(37
|
)
|
|
—
|
|
|
—
|
|
|||
|
Excess tax benefit from share-based plans
|
4
|
|
|
—
|
|
|
—
|
|
|||
|
Return of capital to Agilent
|
(940
|
)
|
|
—
|
|
|
—
|
|
|||
|
Net transfers from (to) Agilent
|
217
|
|
|
(481
|
)
|
|
(552
|
)
|
|||
|
Net cash provided by (used in) financing activities
|
335
|
|
|
(481
|
)
|
|
(552
|
)
|
|||
|
Effect of exchange rate movements
|
(6
|
)
|
|
—
|
|
|
—
|
|
|||
|
Net increase in cash and cash equivalents
|
810
|
|
|
—
|
|
|
—
|
|
|||
|
Cash and cash equivalents at beginning of year
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Cash and cash equivalents at end of year
|
$
|
810
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
Common Stock
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
|
Number of Shares
|
|
Par Value
|
|
Additional Paid-in Capital
|
|
Retained Earnings
|
|
Accumulated Other Comprehensive Income/(Loss)
|
Agilent Net Investment
|
|
Total Equity
|
||||||||||||||
|
|
(in millions, except number of shares in thousands)
|
|||||||||||||||||||||||||
|
Balance as of October 31, 2011
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
115
|
|
|
$
|
881
|
|
|
$
|
996
|
|
|
Components of comprehensive income, net of tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
841
|
|
|
841
|
|
||||||
|
Other comprehensive loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(14
|
)
|
|
—
|
|
|
(14
|
)
|
||||||
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
827
|
|
||||||
|
Net transfers to Agilent
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(518
|
)
|
|
(518
|
)
|
||||||
|
Balance as of October 31, 2012
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
101
|
|
|
$
|
1,204
|
|
|
$
|
1,305
|
|
|
Components of comprehensive income, net of tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
457
|
|
|
457
|
|
||||||
|
Other comprehensive loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(70
|
)
|
|
—
|
|
|
(70
|
)
|
||||||
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
387
|
|
||||||
|
Net transfers to Agilent
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(447
|
)
|
|
(447
|
)
|
||||||
|
Balance as of October 31, 2013
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
31
|
|
|
$
|
1,214
|
|
|
$
|
1,245
|
|
|
Components of comprehensive income, net of tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net income (pre-capitalization)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
291
|
|
|
291
|
|
||||||
|
Net income (post-capitalization)
|
—
|
|
|
—
|
|
|
—
|
|
|
101
|
|
|
—
|
|
|
—
|
|
|
101
|
|
||||||
|
Total net income
|
|
|
|
|
|
|
|
|
|
|
|
|
392
|
|
||||||||||||
|
Other comprehensive loss (pre-capitalization)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(8
|
)
|
|
—
|
|
|
(8
|
)
|
||||||
|
Other comprehensive loss (post-capitalization)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(96
|
)
|
|
—
|
|
|
(96
|
)
|
||||||
|
Total other comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(104
|
)
|
||||||
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
288
|
|
||||||||||||
|
Net transfers to Agilent (pre-capitalization)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(267
|
)
|
|
(267
|
)
|
||||||
|
Transfers due to Capitalization
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(263
|
)
|
|
780
|
|
|
517
|
|
||||||
|
Return of capital to Agilent (post-capitalization)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(900
|
)
|
|
(900
|
)
|
||||||
|
Excess cash paid or payable to Agilent
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(114
|
)
|
|
(114
|
)
|
||||||
|
Issuance of common stock and reclassification of parent company investment in connection with separation
|
167,483
|
|
|
2
|
|
|
1,002
|
|
|
—
|
|
|
—
|
|
|
(1,004
|
)
|
|
—
|
|
||||||
|
Balance as of October 31, 2014
|
167,483
|
|
|
$
|
2
|
|
|
$
|
1,002
|
|
|
$
|
101
|
|
|
$
|
(336
|
)
|
|
$
|
—
|
|
|
$
|
769
|
|
|
|
Years ended October 31,
|
||||||||||
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
Cost of products and services
|
$
|
96
|
|
|
$
|
93
|
|
|
$
|
98
|
|
|
Research and development
|
44
|
|
|
54
|
|
|
58
|
|
|||
|
Selling, general and administrative
|
273
|
|
|
257
|
|
|
246
|
|
|||
|
Other (income) expense
|
(4
|
)
|
|
(4
|
)
|
|
(7
|
)
|
|||
|
Total allocated costs
|
$
|
409
|
|
|
$
|
400
|
|
|
$
|
395
|
|
|
|
October 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
Receivable from Agilent
|
$
|
23
|
|
|
$
|
—
|
|
|
Payable to Agilent
|
$
|
125
|
|
|
$
|
—
|
|
|
|
Years Ended October 31,
|
||||||||||
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
|
(in millions)
|
||||||||||
|
Cost of products and services
|
$
|
11
|
|
|
$
|
9
|
|
|
$
|
8
|
|
|
Research and development
|
7
|
|
|
7
|
|
|
6
|
|
|||
|
Selling, general and administrative
|
26
|
|
|
27
|
|
|
24
|
|
|||
|
Total share-based compensation expense
|
$
|
44
|
|
|
$
|
43
|
|
|
$
|
38
|
|
|
|
Years Ended October 31,
|
||||
|
|
2014
|
|
2013
|
|
2012
|
|
Stock Option Plans:
|
|
|
|
|
|
|
Weighted average risk-free interest rate
|
1.69%
|
|
0.86%
|
|
0.88%
|
|
Dividend yield
|
1%
|
|
1%
|
|
0%
|
|
Weighted average volatility
|
39%
|
|
39%
|
|
38%
|
|
Expected life
|
5.8 years
|
|
5.8 years
|
|
5.8 years
|
|
LTP Program:
|
|
|
|
|
|
|
Volatility of Agilent shares
|
—
|
|
37%
|
|
41%
|
|
Volatility of selected peer-company shares
|
—
|
|
6%-64%
|
|
17%-75%
|
|
Price-wise correlation with selected peers
|
—
|
|
49%
|
|
62%
|
|
|
Options
Outstanding
|
|
Weighted
Average
Exercise Price
|
|||
|
|
(in thousands)
|
|
|
|||
|
Outstanding at October 31, 2013
|
2,320
|
|
|
$
|
31
|
|
|
Granted
|
422
|
|
|
$
|
54
|
|
|
Exercised
|
(1,472
|
)
|
|
$
|
30
|
|
|
Expired
|
(16
|
)
|
|
$
|
29
|
|
|
Employee transition (a)
|
948
|
|
|
$
|
32
|
|
|
Outstanding at October 31, 2014
|
2,202
|
|
|
$
|
36
|
|
|
(a)
|
Employee transition amounts consist of
|
|
i.
|
Option activity for employees transitioning between Agilent and Keysight.
|
|
ii.
|
Grants outstanding with corporate and shared services employees that were not included in grants outstanding at October 31, 2013, as they were not directly identifiable at that time.
|
|
|
Options Outstanding
|
|
Options Exercisable
|
||||||||||||||||||||||
|
Range of
Exercise Prices
|
Number
Outstanding
|
|
Weighted
Average
Remaining
Contractual
Life
|
|
Weighted
Average
Exercise
Price
|
|
Aggregate
Intrinsic
Value
|
|
Number
Exercisable
|
|
Weighted
Average
Remaining
Contractual
Life
|
|
Weighted
Average
Exercise
Price
|
|
Aggregate
Intrinsic
Value
|
||||||||||
|
|
(in thousands)
|
|
(in years)
|
|
|
|
(in thousands)
|
|
(in thousands)
|
|
(in years)
|
|
|
|
(in thousands)
|
||||||||||
|
$0 - 25
|
281
|
|
|
1.5
|
|
$
|
20
|
|
|
$
|
9,804
|
|
|
281
|
|
|
1.5
|
|
$
|
20
|
|
|
$
|
9,804
|
|
|
$25.01 - 30
|
119
|
|
|
4.4
|
|
$
|
29
|
|
|
3,083
|
|
|
119
|
|
|
4.4
|
|
$
|
29
|
|
|
3,084
|
|
||
|
$30.01 - 40
|
1,380
|
|
|
4.8
|
|
$
|
35
|
|
|
28,542
|
|
|
752
|
|
|
2.5
|
|
$
|
33
|
|
|
16,566
|
|
||
|
$40.01 & over
|
422
|
|
|
9.1
|
|
$
|
54
|
|
|
727
|
|
|
—
|
|
|
0
|
|
$
|
—
|
|
|
—
|
|
||
|
|
2,202
|
|
|
5.2
|
|
$
|
36
|
|
|
$
|
42,156
|
|
|
1,152
|
|
|
2.5
|
|
$
|
30
|
|
|
$
|
29,454
|
|
|
|
Aggregate
Intrinsic Value
|
|
Weighted
Average
Exercise
Price
|
|
Per Share Value Using
Black-Scholes
Model
|
||||||
|
|
(in thousands)
|
|
|
|
|
||||||
|
Options exercised in fiscal 2012
|
$
|
18,694
|
|
|
$
|
22
|
|
|
|
|
|
|
Black-Scholes per share value of options granted during fiscal 2012
|
|
|
|
|
|
|
$
|
14
|
|
||
|
Options exercised in fiscal 2013
|
$
|
26,808
|
|
|
$
|
28
|
|
|
|
|
|
|
Black-Scholes per share value of options granted during fiscal 2013
|
|
|
|
|
|
|
$
|
12
|
|
||
|
Options exercised in fiscal 2014
|
$
|
39,886
|
|
|
$
|
30
|
|
|
|
|
|
|
Black-Scholes per share value of options granted during fiscal 2014
|
|
|
|
|
|
|
$
|
19
|
|
||
|
|
Shares
|
|
Weighted
Average
Grant Price
|
|||
|
|
(in thousands)
|
|
|
|||
|
Non-vested at October 31, 2013
|
1,086
|
|
|
$
|
37
|
|
|
Granted
|
532
|
|
|
$
|
54
|
|
|
Vested
|
(545
|
)
|
|
$
|
36
|
|
|
Forfeited
|
(15
|
)
|
|
$
|
43
|
|
|
Change in LTP Program shares vested in the year due to performance conditions
|
(12
|
)
|
|
$
|
36
|
|
|
Employee transition (a)
|
376
|
|
|
$
|
37
|
|
|
Non-vested at October 31, 2014
|
1,422
|
|
|
$
|
44
|
|
|
(a)
|
Employee transition amounts consist of:
|
|
i.
|
Stock activity for employees transitioning between Agilent and Keysight.
|
|
ii.
|
Unvested stock with corporate and shared services employees that were not included in grants outstanding at October 31, 2013, as they were not directly identifiable at that time.
|
|
|
Years Ended October 31,
|
||||||||||
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
|
(in millions)
|
||||||||||
|
U.S. operations
|
$
|
(18
|
)
|
|
$
|
14
|
|
|
$
|
50
|
|
|
Non-U.S. operations
|
493
|
|
|
487
|
|
|
696
|
|
|||
|
Total income before taxes
|
$
|
475
|
|
|
$
|
501
|
|
|
$
|
746
|
|
|
|
Years Ended October 31,
|
||||||||||
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
|
(in millions)
|
||||||||||
|
U.S. federal taxes:
|
|
|
|
|
|
||||||
|
Current
|
$
|
(11
|
)
|
|
$
|
10
|
|
|
$
|
15
|
|
|
Deferred
|
25
|
|
|
12
|
|
|
(124
|
)
|
|||
|
Non-U.S. taxes:
|
|
|
|
|
|
||||||
|
Current
|
62
|
|
|
16
|
|
|
7
|
|
|||
|
Deferred
|
(4
|
)
|
|
3
|
|
|
6
|
|
|||
|
State taxes, net of federal benefit:
|
|
|
|
|
|
||||||
|
Current
|
9
|
|
|
4
|
|
|
1
|
|
|||
|
Deferred
|
2
|
|
|
(1
|
)
|
|
—
|
|
|||
|
Total provision
|
$
|
83
|
|
|
$
|
44
|
|
|
$
|
(95
|
)
|
|
|
October 31,
|
||||||||||||||
|
|
2014
|
|
2013
|
||||||||||||
|
|
Deferred
Tax Assets
|
|
Deferred Tax
Liabilities
|
|
Deferred
Tax Assets
|
|
Deferred Tax
Liabilities
|
||||||||
|
|
(in millions)
|
||||||||||||||
|
Inventory
|
$
|
20
|
|
|
$
|
—
|
|
|
$
|
11
|
|
|
$
|
(1
|
)
|
|
Intangibles
|
35
|
|
|
(6
|
)
|
|
9
|
|
|
—
|
|
||||
|
Property, plant and equipment
|
28
|
|
|
(10
|
)
|
|
11
|
|
|
(6
|
)
|
||||
|
Warranty reserves
|
18
|
|
|
—
|
|
|
12
|
|
|
—
|
|
||||
|
Pension benefits
|
61
|
|
|
(18
|
)
|
|
—
|
|
|
—
|
|
||||
|
Employee benefits, other than retirement
|
26
|
|
|
—
|
|
|
31
|
|
|
(1
|
)
|
||||
|
Net operating loss, capital loss, and credit carryforwards
|
127
|
|
|
—
|
|
|
214
|
|
|
—
|
|
||||
|
State taxes
|
6
|
|
|
—
|
|
|
3
|
|
|
—
|
|
||||
|
Unremitted earnings of foreign subsidiaries
|
—
|
|
|
(53
|
)
|
|
—
|
|
|
(120
|
)
|
||||
|
Share-based compensation
|
15
|
|
|
—
|
|
|
8
|
|
|
—
|
|
||||
|
Deferred revenue
|
42
|
|
|
(1
|
)
|
|
11
|
|
|
(1
|
)
|
||||
|
Other
|
3
|
|
|
(11
|
)
|
|
15
|
|
|
(11
|
)
|
||||
|
Subtotal
|
381
|
|
|
(99
|
)
|
|
325
|
|
|
(140
|
)
|
||||
|
Tax valuation allowance
|
(39
|
)
|
|
—
|
|
|
(41
|
)
|
|
—
|
|
||||
|
Total deferred tax assets or deferred tax liabilities
|
$
|
342
|
|
|
$
|
(99
|
)
|
|
$
|
284
|
|
|
$
|
(140
|
)
|
|
|
October 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
|
(in millions)
|
||||||
|
Current deferred tax assets
|
$
|
83
|
|
|
$
|
65
|
|
|
Long-term deferred tax assets
|
163
|
|
|
88
|
|
||
|
Current deferred tax liabilities (included within other accrued liabilities)
|
(1
|
)
|
|
(6
|
)
|
||
|
Long-term deferred tax liabilities (included within other long-term liabilities)
|
(2
|
)
|
|
(3
|
)
|
||
|
Total
|
$
|
243
|
|
|
$
|
144
|
|
|
|
Years Ended October 31,
|
||||||||||
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
|
(in millions)
|
||||||||||
|
Profit before tax times statutory rate
|
$
|
166
|
|
|
$
|
175
|
|
|
$
|
261
|
|
|
State income taxes, net of federal benefit
|
6
|
|
|
2
|
|
|
1
|
|
|||
|
Non-U.S. income taxed at different rates
|
(113
|
)
|
|
(147
|
)
|
|
(209
|
)
|
|||
|
Repatriation of foreign earnings
|
62
|
|
|
8
|
|
|
73
|
|
|||
|
Change in unrecognized tax benefits
|
(39
|
)
|
|
6
|
|
|
—
|
|
|||
|
Valuation allowances
|
(5
|
)
|
|
—
|
|
|
(227
|
)
|
|||
|
Other, net
|
6
|
|
|
—
|
|
|
6
|
|
|||
|
Provision for income taxes
|
$
|
83
|
|
|
$
|
44
|
|
|
$
|
(95
|
)
|
|
Effective tax rate
|
18
|
%
|
|
9
|
%
|
|
(13
|
)%
|
|||
|
|
October 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
|
(in millions)
|
||||||
|
Current income tax liabilities (included within income and other taxes payable)
)
|
$
|
(60
|
)
|
|
$
|
(20
|
)
|
|
Long-term income tax liabilities (included within other long-term liabilities)
|
(82
|
)
|
|
(92
|
)
|
||
|
Total
|
$
|
(142
|
)
|
|
$
|
(112
|
)
|
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
|
(in millions)
|
||||||||||
|
Balance, beginning of year
|
$
|
173
|
|
|
$
|
162
|
|
|
$
|
193
|
|
|
Additions for tax positions related to the current year
|
10
|
|
|
9
|
|
|
9
|
|
|||
|
Additions for tax positions from prior years
|
9
|
|
|
5
|
|
|
22
|
|
|||
|
Reductions for tax positions from prior years
|
(59
|
)
|
|
(2
|
)
|
|
(27
|
)
|
|||
|
Settlements with taxing authorities
|
(1
|
)
|
|
—
|
|
|
(25
|
)
|
|||
|
Statute of limitations expirations
|
(3
|
)
|
|
(1
|
)
|
|
(10
|
)
|
|||
|
Balance, end of year
|
$
|
129
|
|
|
$
|
173
|
|
|
$
|
162
|
|
|
|
Years Ended October 31,
|
||||||||||
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
|
(in millions)
|
||||||||||
|
Numerator:
|
|
|
|
|
|
||||||
|
Net income
|
$
|
392
|
|
|
$
|
457
|
|
|
$
|
841
|
|
|
Denominator:
|
|
|
|
|
|
||||||
|
Basic and diluted weighted average shares
|
167
|
|
|
167
|
|
|
167
|
|
|||
|
Basic and diluted net income per share
|
$
|
2.35
|
|
|
$
|
2.74
|
|
|
$
|
5.04
|
|
|
|
October 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
|
(in millions)
|
||||||
|
Finished goods
|
$
|
219
|
|
|
$
|
209
|
|
|
Purchased parts and fabricated assemblies
|
279
|
|
|
293
|
|
||
|
Inventory
|
$
|
498
|
|
|
$
|
502
|
|
|
|
October 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
|
(in millions)
|
||||||
|
Land
|
$
|
61
|
|
|
$
|
68
|
|
|
Buildings and leasehold improvements
|
627
|
|
|
647
|
|
||
|
Machinery and equipment
|
861
|
|
|
512
|
|
||
|
Software
|
6
|
|
|
8
|
|
||
|
Total property, plant and equipment
|
1,555
|
|
|
1,235
|
|
||
|
Accumulated depreciation and amortization
|
(1,085
|
)
|
|
(766
|
)
|
||
|
Property, plant and equipment, net
|
$
|
470
|
|
|
$
|
469
|
|
|
|
Customer Support and Services
|
|
Measurement Solutions
|
|
Total
|
||||||
|
|
(in millions)
|
||||||||||
|
Goodwill as of October 31, 2012
|
$
|
60
|
|
|
$
|
407
|
|
|
$
|
467
|
|
|
Foreign currency translation impact
|
(6
|
)
|
|
(41
|
)
|
|
(47
|
)
|
|||
|
Goodwill arising from acquisitions and other adjustments
|
—
|
|
|
(1
|
)
|
|
(1
|
)
|
|||
|
Goodwill as of October 31, 2013
|
$
|
54
|
|
|
$
|
365
|
|
|
$
|
419
|
|
|
Foreign currency translation impact
|
(4
|
)
|
|
(28
|
)
|
|
(32
|
)
|
|||
|
Goodwill arising from acquisitions and other adjustments
|
5
|
|
|
—
|
|
|
5
|
|
|||
|
Goodwill as of October 31, 2014
|
$
|
55
|
|
|
$
|
337
|
|
|
$
|
392
|
|
|
|
Other Intangible Assets
|
||||||||||
|
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
and Impairments
|
|
Net Book
Value
|
||||||
|
|
(in millions)
|
||||||||||
|
As of October 31, 2013:
|
|
|
|
|
|
||||||
|
Developed technology
|
$
|
123
|
|
|
$
|
108
|
|
|
$
|
15
|
|
|
Backlog
|
4
|
|
|
4
|
|
|
—
|
|
|||
|
Trademark/Tradename
|
1
|
|
|
1
|
|
|
—
|
|
|||
|
Customer relationships
|
26
|
|
|
23
|
|
|
3
|
|
|||
|
Total amortizable intangible assets
|
$
|
154
|
|
|
$
|
136
|
|
|
$
|
18
|
|
|
In-Process R&D
|
2
|
|
|
—
|
|
|
2
|
|
|||
|
Total
|
$
|
156
|
|
|
$
|
136
|
|
|
$
|
20
|
|
|
As of October 31, 2014:
|
|
|
|
|
|
||||||
|
Developed technology
|
$
|
125
|
|
|
$
|
114
|
|
|
$
|
11
|
|
|
Backlog
|
4
|
|
|
4
|
|
|
—
|
|
|||
|
Trademark/Tradename
|
1
|
|
|
1
|
|
|
—
|
|
|||
|
Customer relationships
|
32
|
|
|
25
|
|
|
7
|
|
|||
|
Total amortizable intangible assets
|
$
|
162
|
|
|
$
|
144
|
|
|
$
|
18
|
|
|
In-Process R&D
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Total
|
$
|
162
|
|
|
$
|
144
|
|
|
$
|
18
|
|
|
|
October 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
|
(in millions)
|
||||||
|
Long-Term
|
|
|
|
||||
|
Cost method investments
|
$
|
15
|
|
|
$
|
10
|
|
|
Trading securities
|
13
|
|
|
11
|
|
||
|
Available-for-sale investments
|
35
|
|
|
23
|
|
||
|
Total
|
$
|
63
|
|
|
$
|
44
|
|
|
|
October 31, 2014
|
|
October 31, 2013
|
||||||||||||||||||||||||||||
|
|
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Estimated
Fair
Value
|
|
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Estimated
Fair
Value
|
||||||||||||||||
|
|
(in millions)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
Equity securities
|
$
|
15
|
|
|
$
|
20
|
|
|
$
|
—
|
|
|
$
|
35
|
|
|
$
|
15
|
|
|
$
|
8
|
|
|
$
|
—
|
|
|
$
|
23
|
|
|
|
|
|
Fair Value Measurement at
October 31, 2014 Using |
||||||||||||
|
|
October 31,
2014 |
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
|
(in millions)
|
||||||||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Short-term
|
|
|
|
|
|
|
|
||||||||
|
Cash equivalents (money market funds)
|
$
|
634
|
|
|
$
|
634
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Derivative instruments (foreign exchange contracts)
|
9
|
|
|
—
|
|
|
9
|
|
|
—
|
|
||||
|
Long-term
|
|
|
|
|
|
|
|
||||||||
|
Trading securities
|
13
|
|
|
13
|
|
|
—
|
|
|
—
|
|
||||
|
Available-for-sale investments
|
35
|
|
|
35
|
|
|
—
|
|
|
—
|
|
||||
|
Total assets measured at fair value
|
$
|
691
|
|
|
$
|
682
|
|
|
$
|
9
|
|
|
$
|
—
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Short-term
|
|
|
|
|
|
|
|
||||||||
|
Derivative instruments (foreign exchange contracts)
|
$
|
3
|
|
|
$
|
—
|
|
|
$
|
3
|
|
|
$
|
—
|
|
|
Long-term
|
|
|
|
|
|
|
|
||||||||
|
Deferred compensation liability
|
13
|
|
|
—
|
|
|
13
|
|
|
—
|
|
||||
|
Total liabilities measured at fair value
|
$
|
16
|
|
|
$
|
—
|
|
|
$
|
16
|
|
|
$
|
—
|
|
|
|
|
|
Fair Value Measurement at
October 31, 2013 Using
|
||||||||||||
|
|
October 31,
2013 |
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
|
(in millions)
|
||||||||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Long-term
|
|
|
|
|
|
|
|
||||||||
|
Trading securities
|
$
|
11
|
|
|
$
|
11
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Available-for-sale investments
|
23
|
|
|
23
|
|
|
—
|
|
|
—
|
|
||||
|
Total assets measured at fair value
|
$
|
34
|
|
|
$
|
34
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Long-term
|
|
|
|
|
|
|
|
||||||||
|
Deferred compensation liability
|
11
|
|
|
—
|
|
|
11
|
|
|
—
|
|
||||
|
Total liabilities measured at fair value
|
$
|
11
|
|
|
$
|
—
|
|
|
$
|
11
|
|
|
$
|
—
|
|
|
|
Years Ended
October 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
|
(in millions)
|
||||||
|
Long-lived assets held and used
|
$
|
—
|
|
|
$
|
1
|
|
|
|
|
Derivatives in
Cash Flow
Hedging Relationships
|
|
Derivatives
Not
Designated
as Hedging
Instruments
|
||||||||
|
|
|
Forward
Contracts
|
|
Option
Contracts
|
|
Forward
Contracts
|
||||||
|
Currency
|
|
Buy/(Sell)
|
|
Buy/(Sell)
|
|
Buy/(Sell)
|
||||||
|
|
|
(in millions)
|
||||||||||
|
Euro
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
22
|
|
|
British Pound
|
|
—
|
|
|
—
|
|
|
39
|
|
|||
|
Malaysian Ringgit
|
|
91
|
|
|
—
|
|
|
19
|
|
|||
|
Japanese Yen
|
|
(86
|
)
|
|
(23
|
)
|
|
(34
|
)
|
|||
|
Other
|
|
(15
|
)
|
|
—
|
|
|
8
|
|
|||
|
|
|
$
|
(10
|
)
|
|
$
|
(23
|
)
|
|
$
|
54
|
|
|
Fair Values of Derivative Instruments
|
||||||||||||||||||
|
Asset Derivatives
|
|
Liability Derivatives
|
||||||||||||||||
|
|
|
Fair Value
|
|
|
|
Fair Value
|
||||||||||||
|
Balance Sheet Location
|
|
October 31,
2014 |
|
October 31,
2013 |
|
Balance Sheet Location
|
|
October 31,
2014 |
|
October 31,
2013 |
||||||||
|
(in millions)
|
||||||||||||||||||
|
Derivatives designated as hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Cash flow hedges
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Foreign exchange contracts
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Other current assets
|
|
$
|
7
|
|
|
$
|
—
|
|
|
Other accrued liabilities
|
|
$
|
1
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Foreign exchange contracts
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Other current assets
|
|
2
|
|
|
—
|
|
|
Other accrued liabilities
|
|
2
|
|
|
—
|
|
||||
|
Total derivatives
|
|
$
|
9
|
|
|
$
|
—
|
|
|
|
|
$
|
3
|
|
|
$
|
—
|
|
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
|
(in millions)
|
||||||||||
|
Derivatives designated as hedging instruments:
|
|
|
|
|
|
||||||
|
Cash flow hedges
|
|
|
|
|
|
||||||
|
Gain recognized in accumulated other comprehensive income
|
$
|
5
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
|
||||||
|
Gain (loss) recognized in other income (expense), net
|
$
|
3
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
Workforce
Reduction
|
||
|
|
(in millions)
|
||
|
Balance as of October 31, 2013
|
$
|
6
|
|
|
Income statement expense (reversal)
|
(3
|
)
|
|
|
Cash payments
|
(2
|
)
|
|
|
Balance as of October 31, 2014
|
$
|
1
|
|
|
|
Year Ended
|
||||||
|
|
October 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
|
(in millions)
|
|
|
||||
|
Cost of products and services
|
$
|
(1
|
)
|
|
$
|
4
|
|
|
Research and development
|
(1
|
)
|
|
5
|
|
||
|
Selling, general and administrative
|
(1
|
)
|
|
6
|
|
||
|
Total restructuring, asset impairments and other special charges
|
$
|
(3
|
)
|
|
$
|
15
|
|
|
|
Defined Benefit Plans
|
|
U.S. Post-Retirement Benefit Plan
|
||||||||||||||||||||||||||||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
|
|||||||||||||||||||||||||||||||
|
|
2014
|
|
2013
|
|
2012
|
|
2014
|
|
2013
|
|
2012
|
|
2014
|
|
2013
|
|
2012
|
||||||||||||||||||
|
|
(in millions)
|
||||||||||||||||||||||||||||||||||
|
Net periodic benefit cost (benefit)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Service cost — benefits earned during the period
|
$
|
5
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
4
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Interest cost on benefit obligation
|
5
|
|
|
—
|
|
|
—
|
|
|
11
|
|
|
—
|
|
|
—
|
|
|
2
|
|
|
—
|
|
|
—
|
|
|||||||||
|
Expected return on plan assets
|
(10
|
)
|
|
—
|
|
|
—
|
|
|
(19
|
)
|
|
—
|
|
|
—
|
|
|
(4
|
)
|
|
—
|
|
|
—
|
|
|||||||||
|
Amortization of net actuarial loss
|
1
|
|
|
—
|
|
|
—
|
|
|
7
|
|
|
—
|
|
|
—
|
|
|
2
|
|
|
—
|
|
|
—
|
|
|||||||||
|
Amortization of prior service credit
|
(1
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5
|
)
|
|
—
|
|
|
—
|
|
|||||||||
|
Net periodic benefit cost (benefit)
|
—
|
|
|
—
|
|
|
—
|
|
|
3
|
|
|
—
|
|
|
—
|
|
|
(5
|
)
|
|
—
|
|
|
—
|
|
|||||||||
|
Allocated benefit cost (benefit) from Agilent
|
3
|
|
|
9
|
|
|
8
|
|
|
9
|
|
|
23
|
|
|
26
|
|
|
(9
|
)
|
|
(10
|
)
|
|
(10
|
)
|
|||||||||
|
Total periodic benefit cost (benefit)
|
$
|
3
|
|
|
$
|
9
|
|
|
$
|
8
|
|
|
$
|
12
|
|
|
$
|
23
|
|
|
$
|
26
|
|
|
$
|
(14
|
)
|
|
$
|
(10
|
)
|
|
$
|
(10
|
)
|
|
Other changes in plan assets and benefit obligations recognized in other comprehensive (income) loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Prior service credits assumed at Capitalization
|
$
|
(33
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(3
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(102
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Net actuarial loss assumed at Capitalization
|
40
|
|
|
|
|
|
|
|
|
367
|
|
|
|
|
|
|
|
|
75
|
|
|
|
|
|
|
|
|||||||||
|
Net actuarial loss
|
5
|
|
|
—
|
|
|
—
|
|
|
39
|
|
|
—
|
|
|
—
|
|
|
7
|
|
|
—
|
|
|
—
|
|
|||||||||
|
Amortization of net actuarial loss
|
(1
|
)
|
|
—
|
|
|
—
|
|
|
(7
|
)
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
—
|
|
|
—
|
|
|||||||||
|
Amortization of prior service credit
|
1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5
|
|
|
—
|
|
|
—
|
|
|||||||||
|
Foreign currency
|
—
|
|
|
—
|
|
|
—
|
|
|
9
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||
|
Total recognized in other comprehensive (income) loss
|
$
|
12
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
405
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(17
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Total recognized in net periodic benefit cost (benefit) and other comprehensive (income) loss
|
$
|
15
|
|
|
$
|
9
|
|
|
$
|
8
|
|
|
$
|
417
|
|
|
$
|
23
|
|
|
$
|
26
|
|
|
$
|
(31
|
)
|
|
$
|
(10
|
)
|
|
$
|
(10
|
)
|
|
|
U.S. Defined
Benefit Plans
|
|
Non-U.S. Defined
Benefit Plans
|
|
U.S.
Post-Retirement
Benefit Plan
|
||||||||||||||||||
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||||||
|
|
(in millions)
|
||||||||||||||||||||||
|
Change in fair value of plan assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Fair value — beginning of year
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Assets received at Capitalization
|
490
|
|
|
—
|
|
|
1,358
|
|
|
—
|
|
|
189
|
|
|
—
|
|
||||||
|
Actual return on plan assets
|
7
|
|
|
—
|
|
|
46
|
|
|
—
|
|
|
2
|
|
|
—
|
|
||||||
|
Employer contributions
|
—
|
|
|
—
|
|
|
10
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Benefits paid
|
(6
|
)
|
|
—
|
|
|
(9
|
)
|
|
—
|
|
|
(4
|
)
|
|
—
|
|
||||||
|
Currency impact
|
—
|
|
|
—
|
|
|
(87
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Fair value — end of year
|
$
|
491
|
|
|
$
|
—
|
|
|
$
|
1,318
|
|
|
$
|
—
|
|
|
$
|
187
|
|
|
$
|
—
|
|
|
Change in benefit obligation:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Benefit obligation — beginning of year
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Liabilities assumed at Capitalization
|
508
|
|
|
—
|
|
|
1,446
|
|
|
—
|
|
|
203
|
|
|
|
|
||||||
|
Service cost
|
5
|
|
|
—
|
|
|
4
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Interest cost
|
5
|
|
|
—
|
|
|
11
|
|
|
—
|
|
|
2
|
|
|
—
|
|
||||||
|
Plan amendment
|
—
|
|
|
—
|
|
|
(1
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Actuarial loss
|
2
|
|
|
—
|
|
|
70
|
|
|
—
|
|
|
5
|
|
|
—
|
|
||||||
|
Benefits paid
|
(6
|
)
|
|
—
|
|
|
(9
|
)
|
|
—
|
|
|
(4
|
)
|
|
—
|
|
||||||
|
Currency impact
|
—
|
|
|
—
|
|
|
(92
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Benefit obligation — end of year
|
$
|
514
|
|
|
$
|
—
|
|
|
$
|
1,429
|
|
|
$
|
—
|
|
|
$
|
206
|
|
|
$
|
—
|
|
|
Underfunded status of PBO
|
$
|
(23
|
)
|
|
$
|
—
|
|
|
$
|
(111
|
)
|
|
$
|
—
|
|
|
$
|
(19
|
)
|
|
$
|
—
|
|
|
Amounts recognized in the combined and consolidated balance sheet consist of:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Other assets
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
48
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Employee compensation and benefits
|
(1
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Retirement and post-retirement benefits
|
(22
|
)
|
|
—
|
|
|
(159
|
)
|
|
—
|
|
|
(19
|
)
|
|
—
|
|
||||||
|
Net liability
|
$
|
(23
|
)
|
|
$
|
—
|
|
|
$
|
(111
|
)
|
|
$
|
—
|
|
|
$
|
(19
|
)
|
|
$
|
—
|
|
|
Amounts recognized in accumulated other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Actuarial losses
|
$
|
44
|
|
|
$
|
—
|
|
|
$
|
408
|
|
|
$
|
—
|
|
|
$
|
80
|
|
|
$
|
—
|
|
|
Prior service credits
|
(32
|
)
|
|
—
|
|
|
(3
|
)
|
|
—
|
|
|
(97
|
)
|
|
—
|
|
||||||
|
Total
|
$
|
12
|
|
|
$
|
—
|
|
|
$
|
405
|
|
|
$
|
—
|
|
|
$
|
(17
|
)
|
|
$
|
—
|
|
|
|
U.S. Defined
Benefit Plans
|
|
Non-U.S. Defined
Benefit Plans
|
|
U.S. Post-Retirement
Benefit Plan
|
||||||
|
|
(in millions)
|
||||||||||
|
Amortization of net prior service credit
|
$
|
(7
|
)
|
|
$
|
(1
|
)
|
|
$
|
(21
|
)
|
|
Amortization of actuarial net loss
|
$
|
4
|
|
|
$
|
29
|
|
|
$
|
12
|
|
|
|
|
|
Fair Value Measurement
at October 31, 2014 Using
|
||||||||||||
|
|
October 31,
2014 |
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
|
(in millions)
|
||||||||||||||
|
Cash and Cash Equivalents
|
$
|
6
|
|
|
$
|
1
|
|
|
$
|
5
|
|
|
$
|
—
|
|
|
Equity
|
365
|
|
|
86
|
|
|
279
|
|
|
—
|
|
||||
|
Fixed Income
|
120
|
|
|
40
|
|
|
80
|
|
|
—
|
|
||||
|
Other Investments
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Total assets measured at fair value
|
$
|
491
|
|
|
$
|
127
|
|
|
$
|
364
|
|
|
$
|
—
|
|
|
|
|
|
Fair Value Measurement at
October 31, 2014 Using
|
||||||||||||
|
|
October 31,
2014 |
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
|
(in millions)
|
||||||||||||||
|
Cash and Cash Equivalents
|
$
|
3
|
|
|
$
|
1
|
|
|
$
|
2
|
|
|
$
|
—
|
|
|
Equity
|
143
|
|
|
34
|
|
|
109
|
|
|
—
|
|
||||
|
Fixed Income
|
41
|
|
|
14
|
|
|
27
|
|
|
—
|
|
||||
|
Other Investments
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Total assets measured at fair value
|
$
|
187
|
|
|
$
|
49
|
|
|
$
|
138
|
|
|
$
|
—
|
|
|
|
|
|
Fair Value Measurement at
October 31, 2014 Using
|
||||||||||||
|
|
October 31,
2014 |
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
|
(in millions)
|
||||||||||||||
|
Cash and Cash Equivalents
|
$
|
5
|
|
|
$
|
2
|
|
|
$
|
3
|
|
|
$
|
—
|
|
|
Equity
|
672
|
|
|
150
|
|
|
522
|
|
|
—
|
|
||||
|
Fixed Income
|
603
|
|
|
23
|
|
|
580
|
|
|
—
|
|
||||
|
Other Investments
|
38
|
|
|
—
|
|
|
21
|
|
|
17
|
|
||||
|
Total assets measured at fair value
|
$
|
1,318
|
|
|
$
|
175
|
|
|
$
|
1,126
|
|
|
$
|
17
|
|
|
Balance, beginning of year
|
$
|
—
|
|
|
Realized gains
|
—
|
|
|
|
Unrealized gains/(losses)
|
1
|
|
|
|
Purchases, sales, issuances, and settlements
|
(5
|
)
|
|
|
Transfers in (out)
|
21
|
|
|
|
Balance, end of year
|
$
|
17
|
|
|
|
Benefit
Obligation
|
|
|
||||
|
|
Fair Value of
Plan Assets
|
||||||
|
|
PBO
|
|
|||||
|
|
(in millions)
|
||||||
|
U.S. defined benefit plans where PBO exceeds the fair value of plan assets
|
$
|
514
|
|
|
$
|
491
|
|
|
U.S. defined benefit plans where fair value of plan assets exceeds PBO
|
—
|
|
|
—
|
|
||
|
Total
|
$
|
514
|
|
|
$
|
491
|
|
|
Non-U.S. defined benefit plans where PBO exceeds or is equal to the fair value of plan assets
|
$
|
1,111
|
|
|
$
|
952
|
|
|
Non-U.S. defined benefit plans where fair value of plan assets exceeds PBO
|
318
|
|
|
366
|
|
||
|
Total
|
$
|
1,429
|
|
|
$
|
1,318
|
|
|
|
|
|
|
||||
|
|
ABO
|
|
|
||||
|
U.S. defined benefit plans where ABO exceeds the fair value of plan assets
|
$
|
5
|
|
|
$
|
—
|
|
|
U.S. defined benefit plans where the fair value of plan assets exceeds ABO
|
472
|
|
|
491
|
|
||
|
Total
|
$
|
477
|
|
|
$
|
491
|
|
|
Non-U.S. defined benefit plans where ABO exceeds or is equal to the fair value of plan assets
|
$
|
1,081
|
|
|
$
|
952
|
|
|
Non-U.S. defined benefit plans where fair value of plan assets exceeds ABO
|
310
|
|
|
366
|
|
||
|
Total
|
$
|
1,391
|
|
|
$
|
1,318
|
|
|
|
U.S. Defined
Benefit Plans
|
|
Non-U.S. Defined
Benefit Plans
|
|
U.S. Post-Retirement
Benefit Plan
|
||||||
|
|
(in millions)
|
||||||||||
|
2015
|
$
|
31
|
|
|
$
|
32
|
|
|
$
|
16
|
|
|
2016
|
$
|
29
|
|
|
$
|
35
|
|
|
$
|
17
|
|
|
2017
|
$
|
32
|
|
|
$
|
37
|
|
|
$
|
17
|
|
|
2018
|
$
|
35
|
|
|
$
|
41
|
|
|
$
|
16
|
|
|
2019
|
$
|
37
|
|
|
$
|
44
|
|
|
$
|
16
|
|
|
2020 - 2024
|
$
|
232
|
|
|
$
|
289
|
|
|
$
|
75
|
|
|
U.S. Defined Benefit Plans:
|
|
|
Discount rate
|
4.00%
|
|
Average increase in compensation levels
|
3.50%
|
|
Expected long-term return on assets
|
8.00%
|
|
Non-U.S. Defined Benefit Plans:
|
|
|
Discount rate
|
1.75-4.25%
|
|
Average increase in compensation levels
|
2.50-3.25%
|
|
Expected long-term return on assets
|
4.00-6.50%
|
|
U.S. Post-Retirement Benefits Plan:
|
|
|
Discount rate
|
4.00%
|
|
Expected long-term return on assets
|
8.00%
|
|
Current medical cost trend rate
|
8.00%
|
|
Ultimate medical cost trend rate
|
3.50%
|
|
Medical cost trend rate decreases to ultimate rate in year
|
2028
|
|
U.S. Defined Benefit Plans:
|
|
|
Discount rate
|
4.00%
|
|
Average increase in compensation levels
|
3.50%
|
|
Non-U.S. Defined Benefit Plans:
|
|
|
Discount rate
|
1.50-4.00%
|
|
Average increase in compensation levels
|
2.50-3.25%
|
|
U.S. Post-Retirement Benefits Plan:
|
|
|
Discount rate
|
3.75%
|
|
Current medical cost trend rate
|
8.00%
|
|
Ultimate medical cost trend rate
|
3.50%
|
|
Medical cost trend rate decreases to ultimate rate in year
|
2028
|
|
|
Years Ended October 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
|
(in millions)
|
||||||
|
Beginning balance
|
$
|
38
|
|
|
$
|
26
|
|
|
Accruals for warranties, including change in estimates
|
46
|
|
|
44
|
|
||
|
Settlements made during the period
|
(33
|
)
|
|
(32
|
)
|
||
|
Ending balance
|
$
|
51
|
|
|
$
|
38
|
|
|
Accruals for warranties due within one year
|
$
|
34
|
|
|
$
|
21
|
|
|
Accruals for warranties due after one year
|
17
|
|
|
17
|
|
||
|
Ending balance
|
$
|
51
|
|
|
$
|
38
|
|
|
|
October 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
|
(in millions)
|
||||||
|
3.30% Senior Notes due 2019
|
$
|
499
|
|
|
$
|
—
|
|
|
4.55% Senior Notes due 2024
|
600
|
|
|
—
|
|
||
|
Total
|
$
|
1,099
|
|
|
$
|
—
|
|
|
|
October 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
|
(in millions)
|
||||||
|
Unrealized gain on equity securities, net of tax (expense) of $(4) and $(3)
|
$
|
16
|
|
|
$
|
5
|
|
|
Foreign currency translation, net of tax (expense) of $(63) and $(85)
|
6
|
|
|
26
|
|
||
|
Unrealized losses on defined benefit plans, net of tax benefit of $42 and $0
|
(361
|
)
|
|
—
|
|
||
|
Unrealized gains (losses) on derivative instruments, net of tax (expense) of $(2) and $0
|
3
|
|
|
—
|
|
||
|
Total accumulated other comprehensive income (loss)
|
$
|
(336
|
)
|
|
$
|
31
|
|
|
|
|
|
|
|
Net defined benefit pension cost and post retirement plan costs:
|
|
|
|
|
||||||||||||||
|
|
Unrealized gain on equity securities
|
|
Foreign currency translation
|
|
Actuarial Losses
|
|
Prior service credits
|
|
Unrealized gains (losses) on derivatives
|
|
Total
|
||||||||||||
|
|
(in millions)
|
||||||||||||||||||||||
|
As of October 31, 2012
|
$
|
—
|
|
|
$
|
101
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
101
|
|
|
Other comprehensive income (loss) before reclassifications
|
8
|
|
|
(69
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(61
|
)
|
||||||
|
Tax (expense) benefit
|
(3
|
)
|
|
(6
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9
|
)
|
||||||
|
Other comprehensive income (loss)
|
5
|
|
|
(75
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(70
|
)
|
||||||
|
As of October 31, 2013 (a)
|
5
|
|
|
26
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
31
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Pre-Capitalization
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Other comprehensive income (loss) before reclassifications
|
9
|
|
|
(15
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(6
|
)
|
||||||
|
Tax (expense) benefit
|
(3
|
)
|
|
1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
||||||
|
Other comprehensive income (loss) for nine months period ended July 31, 2014 (b)
|
6
|
|
|
(14
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(8
|
)
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Capitalization
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Assumption of accumulated unrealized translation adjustment, losses on pension and other post-employment benefits
|
—
|
|
|
31
|
|
|
(483
|
)
|
|
139
|
|
|
—
|
|
|
(313
|
)
|
||||||
|
Tax (expense) benefit
|
3
|
|
|
21
|
|
|
77
|
|
|
(51
|
)
|
|
—
|
|
|
50
|
|
||||||
|
Net assumptions (c)
|
3
|
|
|
52
|
|
|
(406
|
)
|
|
88
|
|
|
—
|
|
|
(263
|
)
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Post Capitalization
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Other comprehensive income (loss) before reclassifications
|
3
|
|
|
(58
|
)
|
|
(60
|
)
|
|
—
|
|
|
5
|
|
|
(110
|
)
|
||||||
|
Amounts reclassified out of accumulated other comprehensive income
|
—
|
|
|
—
|
|
|
9
|
|
|
(8
|
)
|
|
—
|
|
|
1
|
|
||||||
|
Tax (expense) benefit
|
(1
|
)
|
|
—
|
|
|
13
|
|
|
3
|
|
|
(2
|
)
|
|
13
|
|
||||||
|
Other comprehensive income (loss) for three months period ended October 31, 2014 (d)
|
2
|
|
|
(58
|
)
|
|
(38
|
)
|
|
(5
|
)
|
|
3
|
|
|
(96
|
)
|
||||||
|
As of October 31, 2014 (a+b+c+d)
|
$
|
16
|
|
|
$
|
6
|
|
|
$
|
(444
|
)
|
|
$
|
83
|
|
|
$
|
3
|
|
|
$
|
(336
|
)
|
|
Details about accumulated other comprehensive income components
|
Amounts Reclassified from other comprehensive income
|
|
Affected line item in statement of operations
|
||||||
|
|
Year Ended
|
|
|
||||||
|
|
October 31,
|
|
|
||||||
|
|
2014
|
|
2013
|
|
|
||||
|
|
(in millions)
|
|
|
||||||
|
Net defined benefit pension cost and post retirement plan costs:
|
|
|
|
|
|
||||
|
Actuarial net loss
|
$
|
(9
|
)
|
|
$
|
—
|
|
|
|
|
Prior service benefit
|
8
|
|
|
—
|
|
|
|
||
|
|
$
|
(1
|
)
|
|
$
|
—
|
|
|
Total before income tax
|
|
|
—
|
|
|
—
|
|
|
Provision for income tax
|
||
|
|
$
|
(1
|
)
|
|
$
|
—
|
|
|
Total net of income tax
|
|
Total reclassifications for the period
|
$
|
(1
|
)
|
|
$
|
—
|
|
|
|
|
|
Measurement Solutions
|
|
Customer Support and Services
|
|
Total
Segments
|
||||||
|
|
(in millions)
|
||||||||||
|
Year ended October 31, 2014:
|
|
|
|
|
|
||||||
|
Total net revenue
|
$
|
2,533
|
|
|
$
|
400
|
|
|
$
|
2,933
|
|
|
Income from operations
|
$
|
472
|
|
|
$
|
87
|
|
|
$
|
559
|
|
|
Depreciation expense
|
$
|
64
|
|
|
$
|
10
|
|
|
$
|
74
|
|
|
Share-based compensation expense
|
$
|
36
|
|
|
$
|
6
|
|
|
$
|
42
|
|
|
Year ended October 31, 2013:
|
|
|
|
|
|
||||||
|
Total net revenue
|
$
|
2,493
|
|
|
$
|
395
|
|
|
$
|
2,888
|
|
|
Income from operations
|
$
|
451
|
|
|
$
|
93
|
|
|
$
|
544
|
|
|
Depreciation expense
|
$
|
56
|
|
|
$
|
9
|
|
|
$
|
65
|
|
|
Share-based compensation expense
|
$
|
33
|
|
|
$
|
5
|
|
|
$
|
38
|
|
|
Year ended October 31, 2012:
|
|
|
|
|
|
||||||
|
Total net revenue
|
$
|
2,942
|
|
|
$
|
373
|
|
|
$
|
3,315
|
|
|
Income from operations
|
$
|
669
|
|
|
$
|
82
|
|
|
$
|
751
|
|
|
Depreciation expense
|
$
|
49
|
|
|
$
|
6
|
|
|
$
|
55
|
|
|
Share-based compensation expense
|
$
|
33
|
|
|
$
|
4
|
|
|
$
|
37
|
|
|
|
Years Ended October 31,
|
||||||||||
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
|
(in millions)
|
||||||||||
|
Total reportable segments' income from operations
|
$
|
559
|
|
|
$
|
544
|
|
|
$
|
751
|
|
|
Restructuring related costs
|
3
|
|
|
(15
|
)
|
|
—
|
|
|||
|
Asset impairments
|
—
|
|
|
(1
|
)
|
|
—
|
|
|||
|
Transformational programs
|
(1
|
)
|
|
(4
|
)
|
|
(1
|
)
|
|||
|
Amortization of intangibles
|
(8
|
)
|
|
(9
|
)
|
|
(7
|
)
|
|||
|
Acquisition and integration costs
|
(1
|
)
|
|
(8
|
)
|
|
(3
|
)
|
|||
|
Acceleration of share-based compensation expense related to workforce reduction
|
—
|
|
|
(1
|
)
|
|
—
|
|
|||
|
Pre-separation costs
|
(78
|
)
|
|
(2
|
)
|
|
—
|
|
|||
|
Other
|
(5
|
)
|
|
(8
|
)
|
|
(7
|
)
|
|||
|
Interest expense
|
(3
|
)
|
|
—
|
|
|
—
|
|
|||
|
Other income (expense), net
|
9
|
|
|
5
|
|
|
13
|
|
|||
|
Income before taxes, as reported
|
$
|
475
|
|
|
$
|
501
|
|
|
$
|
746
|
|
|
|
Measurement Solutions
|
|
Customer Support & Services
|
|
Total
Segments
|
||||||
|
|
(in millions)
|
||||||||||
|
As of October 31, 2014:
|
|
|
|
|
|
||||||
|
Assets
|
$
|
1,740
|
|
|
$
|
236
|
|
|
$
|
1,976
|
|
|
Capital expenditures
|
$
|
60
|
|
|
$
|
10
|
|
|
$
|
70
|
|
|
As of October 31, 2013:
|
|
|
|
|
|
||||||
|
Assets
|
$
|
1,769
|
|
|
$
|
228
|
|
|
$
|
1,997
|
|
|
Capital expenditures
|
$
|
60
|
|
|
$
|
9
|
|
|
$
|
69
|
|
|
|
October 31,
|
||||||
|
|
2014
|
|
2013
|
||||
|
|
(in millions)
|
||||||
|
Total reportable segments' assets
|
$
|
1,976
|
|
|
$
|
1,997
|
|
|
Cash, cash equivalents and short-term investments
|
810
|
|
|
—
|
|
||
|
Prepaid expenses
|
51
|
|
|
—
|
|
||
|
Other current assets
|
9
|
|
|
8
|
|
||
|
Investments
|
63
|
|
|
44
|
|
||
|
Long-term and other receivables
|
33
|
|
|
60
|
|
||
|
Other
|
108
|
|
|
(81
|
)
|
||
|
Total assets
|
$
|
3,050
|
|
|
$
|
2,028
|
|
|
|
United
States
|
|
China
|
|
Japan
|
|
Rest of the
World
|
|
Total
|
||||||||||
|
|
(in millions)
|
||||||||||||||||||
|
Net revenue:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Year ended October 31, 2014
|
$
|
1,051
|
|
|
$
|
590
|
|
|
$
|
331
|
|
|
$
|
961
|
|
|
$
|
2,933
|
|
|
Year ended October 31, 2013
|
$
|
966
|
|
|
$
|
512
|
|
|
$
|
364
|
|
|
$
|
1,046
|
|
|
$
|
2,888
|
|
|
Year ended October 31, 2012
|
$
|
1,223
|
|
|
$
|
611
|
|
|
$
|
425
|
|
|
$
|
1,056
|
|
|
$
|
3,315
|
|
|
|
United
States
|
|
Japan
|
|
Malaysia
|
|
China
|
|
Rest of the
World
|
|
Total
|
||||||||||||
|
|
(in millions)
|
||||||||||||||||||||||
|
Long-lived assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
October 31, 2014
|
$
|
218
|
|
|
$
|
157
|
|
|
$
|
86
|
|
|
$
|
—
|
|
|
$
|
142
|
|
|
$
|
603
|
|
|
October 31, 2013
|
$
|
194
|
|
|
$
|
122
|
|
|
$
|
94
|
|
|
$
|
51
|
|
|
$
|
60
|
|
|
$
|
521
|
|
|
|
Three Months Ended
|
||||||||||||||
|
|
January 31,
|
|
April 30,
|
|
July 31,
|
|
October 31,
|
||||||||
|
|
(in millions, except per share data)
|
||||||||||||||
|
2014
|
|
|
|
|
|
|
|
||||||||
|
Net revenue
|
$
|
671
|
|
|
$
|
743
|
|
|
$
|
757
|
|
|
$
|
762
|
|
|
Gross profit
|
372
|
|
|
415
|
|
|
414
|
|
|
419
|
|
||||
|
Income from operations
|
91
|
|
|
127
|
|
|
121
|
|
|
130
|
|
||||
|
Net income
|
$
|
74
|
|
|
$
|
110
|
|
|
$
|
107
|
|
|
$
|
101
|
|
|
Net income per share - basic and diluted
(a)
|
$
|
0.44
|
|
|
$
|
0.66
|
|
|
$
|
0.64
|
|
|
$
|
0.60
|
|
|
Basic and diluted average shares outstanding
(a)
|
167
|
|
|
167
|
|
|
167
|
|
|
167
|
|
||||
|
2013
|
|
|
|
|
|
|
|
||||||||
|
Net revenue
|
$
|
722
|
|
|
$
|
760
|
|
|
$
|
701
|
|
|
$
|
705
|
|
|
Gross profit
|
411
|
|
|
426
|
|
|
391
|
|
|
395
|
|
||||
|
Income from operations
|
118
|
|
|
129
|
|
|
121
|
|
|
128
|
|
||||
|
Net income
|
$
|
110
|
|
|
$
|
121
|
|
|
$
|
111
|
|
|
$
|
115
|
|
|
Net income per share - basic and diluted
(a)
|
$
|
0.66
|
|
|
$
|
0.72
|
|
|
$
|
0.66
|
|
|
$
|
0.69
|
|
|
Basic and diluted average shares outstanding
(a)
|
167
|
|
|
167
|
|
|
167
|
|
|
167
|
|
||||
|
(a)
|
The following documents are filed as part of this report:
|
|
1.
|
Financial Statements.
|
|
2.
|
Financial Statement Schedule.
|
|
Column A
|
|
Column B
|
|
Column C
|
|
Column D
|
|
Column E
|
||||||||
|
Description
|
|
Balance at
Beginning of Period |
|
Additions Charged to
Expenses or Other Accounts* |
|
Deductions Credited to Expenses or Other Accounts**
|
|
Balance at
End of Period |
||||||||
|
|
|
(in millions)
|
||||||||||||||
|
2014
|
|
|
|
|
|
|
|
|
||||||||
|
Tax valuation allowance
|
|
$
|
41
|
|
|
$
|
4
|
|
|
$
|
(6
|
)
|
|
$
|
39
|
|
|
2013
|
|
|
|
|
|
|
|
|
||||||||
|
Tax valuation allowance
|
|
$
|
41
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
41
|
|
|
2012
|
|
|
|
|
|
|
|
|
||||||||
|
Tax valuation allowance
|
|
$
|
269
|
|
|
$
|
1
|
|
|
$
|
(229
|
)
|
|
$
|
41
|
|
|
3.
|
Exhibits.
|
|
|
|
|
|
Incorporation by Reference
|
|||||||
|
Exhibit
Number
|
|
Description
|
|
Form
|
|
Date
|
|
Exhibit
Number
|
|
Filed
Herewith
|
|
|
2.1
|
|
|
Separation and Distribution Agreement, dated August 1, 2014, by and between Agilent Technologies, Inc. and Keysight Technologies, Inc.**
|
|
10-12B/A
|
|
8/13/2014
|
|
2.1
|
|
|
|
3.1
|
|
|
Amended and Restated Certificate of Incorporation of Keysight Technologies, Inc.
|
|
8-K
|
|
11/3/2014
|
|
3.1
|
|
|
|
3.2
|
|
|
Amended and Restated Bylaws of Keysight Technologies, Inc.
|
|
8-K
|
|
11/3/2014
|
|
3.2
|
|
|
|
4.1
|
|
|
Indenture, dated as of October 15, 2014, between Keysight Technologies, Inc. and U.S. Bank National Association, as Trustee
|
|
8-K
|
|
10/17/2014
|
|
4.1
|
|
|
|
4.2
|
|
|
First Supplemental Indenture, dated as of October 15, 2014, to the Indenture dated as of October 15, 2014, between Keysight Technologies, Inc. and U.S. Bank National Association, as Trustee
|
|
8-K
|
|
10/17/2014
|
|
4.2
|
|
|
|
4.3
|
|
|
Guarantee, dated as of October 15, 2014, by Agilent Technologies, Inc. in favor of U.S. Bank National Association as Trustee for the Holders of Notes specified therein of Keysight Technologies, Inc.
|
|
8-K
|
|
10/17/2014
|
|
4.3
|
|
|
|
4.4
|
|
|
Registration Rights Agreement, dated as of October 15, 2014, by and among Keysight Technologies, Inc., Agilent Technologies, Inc., and Citigroup Global Markets Inc., Goldman, Sachs & Co., and Merrill Lynch, Pierce, Fenner & Smith Incorporated as representatives of the Initial Purchasers
|
|
8-K
|
|
10/17/2014
|
|
4.4
|
|
|
|
10.1
|
|
|
Services Agreement, dated August 1, 2014, by and between Agilent Technologies, Inc. and Keysight Technologies, Inc.
|
|
10-12B/A
|
|
8/13/2014
|
|
10.1
|
|
|
|
10.2
|
|
|
Tax Matters Agreement, dated August 1, 2014, by and between Agilent Technologies, Inc. and Keysight Technologies, Inc.
|
|
10-12B/A
|
|
8/13/2014
|
|
10.2
|
|
|
|
10.3
|
|
|
Employee Matters Agreement, dated August 1, 2014, by and between Agilent Technologies, Inc. and Keysight Technologies, Inc.
|
|
10-12B/A
|
|
8/13/2014
|
|
10.3
|
|
|
|
10.4
|
|
|
Intellectual Property Matters Agreement, dated August 1, 2014, by and between Agilent Technologies, Inc. and Keysight Technologies, Inc.
|
|
10-12B/A
|
|
8/13/2014
|
|
10.4
|
|
|
|
10.5
|
|
|
Trademark License Agreement, dated August 1, 2014, by and between Agilent Technologies, Inc. and Keysight Technologies, Inc.
|
|
10-12B/A
|
|
8/13/2014
|
|
10.5
|
|
|
|
10.6
|
|
|
Real Estate Matters Agreement, dated August 1, 2014, by and between Agilent Technologies, Inc. and Keysight Technologies, Inc.
|
|
10-12B/A
|
|
8/13/2014
|
|
10.6
|
|
|
|
10.7
|
|
|
Form of Indemnification Agreement
|
|
10-12B/A
|
|
7/18/2014
|
|
10.7
|
|
|
|
10.8
|
|
|
Keysight Technologies, Inc. Employee Stock Purchase Plan*
|
|
10-12B/A
|
|
7/18/2014
|
|
10.8
|
|
|
|
10.9
|
|
|
Keysight Technologies, Inc. 2014 Equity and Incentive Compensation Plan (As Amended and Restated on September 29, 2014)*
|
|
S-8
|
|
10/21/2014
|
|
4.3
|
|
|
|
10.10
|
|
|
Form of Keysight Technologies, Inc. Global Stock Award Agreement (with deferral alternative)*
|
|
8-K
|
|
11/3/2014
|
|
10.2
|
|
|
|
|
|
|
|
Incorporation by Reference
|
|||||||
|
Exhibit
Number
|
|
Description
|
|
Form
|
|
Date
|
|
Exhibit
Number
|
|
Filed
Herewith
|
|
|
10.11
|
|
|
Form of Keysight Technologies, Inc. Global Performance Award Agreement*
|
|
10-12B/A
|
|
7/18/2014
|
|
10.11
|
|
|
|
10.12
|
|
|
Form of Keysight Technologies, Inc. Global Stock Option Award Agreement*
|
|
10-12B/A
|
|
7/18/2014
|
|
10.12
|
|
|
|
10.13
|
|
|
Form of Keysight Technologies, Inc. Non-Employee Director Stock Option Award Agreement*
|
|
10-12B/A
|
|
7/18/2014
|
|
10.13
|
|
|
|
10.14
|
|
|
Form of Keysight Technologies, Inc. Non-Employee Director Stock Award Agreement*
|
|
10-12B/A
|
|
7/18/2014
|
|
10.14
|
|
|
|
10.15
|
|
|
Form of Keysight Technologies, Inc. 2014 Deferred Compensation Plan*
|
|
10-12B/A
|
|
7/18/2014
|
|
10.15
|
|
|
|
10.16
|
|
|
Form of Keysight Technologies, Inc. 2014 Frozen Deferred Compensation Plan*
|
|
10-12B/A
|
|
7/18/2014
|
|
10.16
|
|
|
|
10.17
|
|
|
Form of Keysight Technologies, Inc. Excess Benefit Retirement Plan*
|
|
10-12B/A
|
|
7/18/2014
|
|
10.17
|
|
|
|
10.18
|
|
|
Form of Keysight Technologies, Inc. Supplemental Benefit Retirement Plan*
|
|
10-12B/A
|
|
7/18/2014
|
|
10.18
|
|
|
|
10.19
|
|
|
Agilent Technologies, Inc. France Pension Plan*
|
|
10-12B/A
|
|
8/13/2014
|
|
10.19
|
|
|
|
10.20
|
|
|
Form of Change of Control Severance Agreement*
|
|
8-K
|
|
11/3/2014
|
|
10.1
|
|
|
|
10.21
|
|
|
Credit Agreement, dated September 15, 2014, between Keysight Technologies, Inc., Agilent Technologies, Inc. and the Lenders Party Thereto*
|
|
10-12B/A
|
|
9/22/2014
|
|
10.21
|
|
|
|
10.22
|
|
|
Form of Keysight Technologies, Inc. Deferral Election for Stock Award*
|
|
8-K
|
|
11/3/2014
|
|
10.3
|
|
|
|
11.1
|
|
|
See Note 6, “Net Income Per Share,” to our Combined and Consolidated Financial Statements.
|
|
|
|
|
|
|
|
X
|
|
12.1
|
|
|
Computation of ratio of earnings to fixed charges.
|
|
|
|
|
|
|
|
X
|
|
14.1
|
|
|
See Investor Information in Item 1: Business of this Annual Report on Form 10-K.
|
|
|
|
|
|
|
|
X
|
|
21.1
|
|
|
Subsidiaries of Keysight Technologies, Inc.
|
|
|
|
|
|
|
|
X
|
|
23.1
|
|
|
Consent of Independent Registered Public Accounting Firm.
|
|
|
|
|
|
|
|
X
|
|
24.1
|
|
|
Powers of Attorney. Contained in the signature page of this Annual Report on Form 10-K.
|
|
|
|
|
|
|
|
X
|
|
31.1
|
|
|
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002.
|
|
|
|
|
|
|
|
X
|
|
31.2
|
|
|
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002.
|
|
|
|
|
|
|
|
X
|
|
32.1
|
|
|
Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002.
|
|
|
|
|
|
|
|
X
|
|
32.2
|
|
|
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002.
|
|
|
|
|
|
|
|
X
|
|
99.1
|
|
|
Information Statement of Keysight Technologies, Inc., dated October 8, 2014
|
|
8-K
|
|
11/3/2014
|
|
99.1
|
|
|
|
*
|
Indicates management contract or compensatory plan, contract or arrangement.
|
|
**
|
Certain schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. Keysight will furnish supplemental copies of any such schedules or exhibits to the U.S. Securities and Exchange Commission upon request.
|
|
|
|
KEYSIGHT TECHNOLOGIES, INC.
|
||
|
|
|
|
|
|
|
|
|
BY
|
|
/s/ Stephen D. Williams
|
|
|
|
|
|
Stephen D. Williams
|
|
|
|
|
|
General Counsel and Secretary
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ RONALD S. NERSESIAN
|
|
Director, President and Chief Executive Officer
|
|
December 22, 2014
|
|
Ronald S. Nersesian
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|
|
/s/ NEIL DOUGHERTY
|
|
Senior Vice President and Chief Financial Officer
|
|
December 22, 2014
|
|
Neil Dougherty
|
|
(Principal Financial Officer)
|
|
|
|
|
|
|
|
|
|
/s/ JOHN SKINNER
|
|
Vice President and Corporate Controller
|
|
December 22, 2014
|
|
John Skinner
|
|
(Principal Accounting Officer)
|
|
|
|
|
|
|
|
|
|
/s/ PAUL N. CLARK
|
|
Chairman of the Board
|
|
December 22, 2014
|
|
Paul N. Clark
|
|
|
|
|
|
|
|
|
|
|
|
/s/ JAMES G. CULLEN
|
|
Director
|
|
December 22, 2014
|
|
James G. Cullen
|
|
|
|
|
|
|
|
|
|
|
|
/s/ CHARLES J. DOCKENDORFF
|
|
Director
|
|
December 22, 2014
|
|
Charles J. Dockendorff
|
|
|
|
|
|
|
|
|
|
|
|
/s/ JEAN M. HALLORAN
|
|
Director
|
|
December 22, 2014
|
|
Jean M. Halloran
|
|
|
|
|
|
|
|
|
|
|
|
/s/ RICHARD HAMADA
|
|
Director
|
|
December 22, 2014
|
|
Richard Hamada
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|